Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-03-22
1985-06-04
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544238, 544239, A61K 3150, C07D23706
Patent
active
045214166
ABSTRACT:
4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones 6-[(substituted)-1H- imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and pharmaceutically acceptable acid addition salts thereof are useful as cardiotonic and antihypertensive agents.
The above compounds cause a significant increase in myocardial contractility in the dog and also cause a decrease in blood pressure in the spontaneously hypertensive rat. The compounds are produced by reacting the appropriate .gamma.-oxo-imidazolebutanoic acid with a suitably substituted hydrazine to provide 4,5-dihydro-6-(substituted)imidazolyl-3(2H)-pyridazinones which are oxidized to 6-(substituted)imidazolyl-3(2H)-pyridazinones.
REFERENCES:
patent: 4353905 (1982-10-01), Sircar
patent: 4361563 (1982-11-01), Austel et al.
patent: 4399137 (1983-08-01), Steiner et al.
Bristol James A.
Sircar Ila
Janssen Jerry F.
Rizzo Nicholas S.
Warner-Lambert & Company
LandOfFree
4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-828252